SABBY MANAGEMENT, LLC - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 88 filers reported holding TRILLIUM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$1,229,000
-11.7%
70,000
-51.2%
0.17%
-15.3%
Q2 2021$1,392,000
-35.0%
143,496
-28.1%
0.20%
-53.0%
Q1 2021$2,143,000
-59.3%
199,569
+63.1%
0.42%
-58.7%
Q4 2020$5,265,000
+352.7%
122,375
-57.5%
1.01%
+108.9%
Q1 2020$1,163,000
+787.8%
287,906
+1936.5%
0.48%
+6800.0%
Q1 2016$131,00014,1370.01%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
AWM Investment Company, Inc. 701,138$4,067,0000.67%
Matrix Capital Management Company, LP 2,288,560$13,274,0000.33%
NEA Management Company, LLC 1,250,000$7,250,0000.31%
Stanley-Laman Group, Ltd. 139,403$809,0000.20%
Cormorant Asset Management, LP 500,000$2,900,0000.19%
Tekla Capital Management LLC 468,399$2,717,0000.10%
Wealth Alliance Advisory Group, LLC 21,800$126,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 175,339$1,007,0000.03%
Artal Group S.A. 150,000$870,0000.02%
Baker Brothers Advisors 505,262$2,931,0000.02%
View complete list of TRILLIUM THERAPEUTICS INC shareholders